Post-market Review of the use of biologics in the treatment of severe chronic plaque psoriasis

Page last updated: 17 August 2018

The Pharmaceutical Benefits Advisory Committee (PBAC) Minutes pertaining to the Draft Review Report for the Post-market Review of the use of biologics in the treatment of severe chronic plaque psoriasis are now available on the Review web page.